Phase Angle as a Marker of Muscle Damage, Muscle Fatigue and Inflammation, After Eccentric Exercise
- Conditions
- Phase Angle
- Registration Number
- NCT05583500
- Lead Sponsor
- Universidad Francisco de Vitoria
- Brief Summary
The purpose of this study will be to assess the effectiveness of bioimpedance device (BIA) as a safe, rapid, and non-invasive method of analyzing muscle damage induced by high intensity induced eccentric exercise as an alternative measurement tool against traditional assessment methods.
A sample of 28 sedentary subjects will be recruited, all participants will perform an eccentric exercise protocol.
Measurements will be done before performing the exercise protocol, immediately after finishing the protocol, 3h after the end of the exercise protocol, 24h after the end of the exercise protocol and 48h after the end of the exercise protocol.
The variables analyzed in all subjects will be phase angle, creatinkinase, jumping strength, VAS scale, white blood count cell, quadriceps muscle thickness, Borg scale and anxiety and depression questionnaires.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 28
- Healthy subjets
- Sedentary subjects
- Trained subjects
- Subjects with musculoskeletal pathology
- Previous Surgeries in the last 6 months
- Subjects under pharmacological treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Phase angle change from baseline to 72 hours The phase angle, which is measured via bioelectrical impedance analysis (BIA), InBody 770 ,is a clinically important bioimpedance parameter used for nutritional assessment and evaluating the risk of various diseases. The phase angle was calculated automatically by the BIA device from these two components according to the following formula: phase angle (°) = (reactance/resistance) × (180°/π).
- Secondary Outcome Measures
Name Time Method Creatinkinase (CK concentration) change from baseline to 72 hours CK concentration will be measure in mg/dl with a portal analyzer (SpotchemTM EZ SP-4430), using test strips.
cellular inflammatory markers change from baseline to 72 hours Cellular inflammatory markers will be measured with hematology analyzer (Sysmex KX-21N Automed) in 10\^9/L and % White blood count, lymphocytes, neutrophils, monocytes, eosinophils, basophils will be analyzed
Pain: VAS change from baseline to 72 hours Visual Analogic Scale. Pain will be measured with a visual analog scale from 0 to 10. 0 points is no pain.
Quadriceps thickness change from baseline to 72 hours Quadriceps muscle thickness will be measures in mm. by an ultrasound device
Leg power change from baseline to 72 hours Leg power will be assessed using vertical jump test, with Chronojump platform (CHRONOJUMP Boscosystem)
Trial Locations
- Locations (1)
Universidad Francisco de Vitoria
🇪🇸Pozuelo De Alarcón, Madrid, Spain